 |
 |
 |
 |
|
BELPROMO NEWS
|
- Attending the ASI Show in Orlando, January 3-5, 2010.
Please visit our 8 booths at location #2816.
- Attending the PPAI Show Las Vegas, January 14-18. Please
visit our 16 booths at location #2068 and #2268.
- Long time industry supplier Hurricane Line merges with
Belpromo effective January 4, 2010.
- Belpromo will launch their new website first quarter 2010.
- Distributor Choice Finalist 2009.
- Nominated for Distributors Choice Awards 10/20/2008
- Reaching for 5 Stars. We have obtained a 4.5 Ratiing on
ESP and we are aiming for 5 Stars. We would like to thank
our distributor partners for taking the time to rate us.
-
Overview 4/14/2008
During the week of April 14, 2008, upon the request of
the Commissioner of Food and Drugs, FDA formed an agency-wide
BPA (Bisphenol A) task force to facilitate cross-agency
review of current research and new information on BPA
for all FDA regulated products. As a result of this review,
the task force will make recommendations to the Commissioner
regarding next steps.
As part of the evaluation, the FDA Task Force is reviewing
the concerns presented in the National Toxicology Program
(NTP) Draft Brief published on April 14, 2008 by the U.S.
National Institutes of Health. We also are reviewing the
concerns presented in the Canadian draft risk assessment
released in April 2008 and are coordinating closely with
Health Canada and the Canadian Ministry of the Environment
and Minister of Health. FDA has been reviewing the emerging
literature on BPA on a continuous basis. For example,
FDA has recently completed a review of the available biological
fate data and two recently completed rodent multigeneration
reproductive studies; these studies did not indicate a
safety concern for BPA at current exposure levels. In
addition, FDA is conducting a review of the data on neural
and behavioral effects of BPA exposure.
Based on our ongoing review, we believe there is a large
body of evidence that indicates that FDA-regulated products
containing BPA currently on the market are safe and that
exposure levels to BPA from food contact materials, including
for infants and children, are below those that may cause
health effects. However, we will continue to consider
new research and information as they become available.
This position is consistent with two risk assessments
for BPA conducted by the European Food Safety Authority
(EFSA) Scientific Panel on Food Additives, Flavourings,
Processing Aids and Materials in Contact with Food and
the Japanese National Institute of Advanced Industrial
Science and Technology. Each of these documents considered
the question of a possible low-dose effect and concluded
that no current health risk exists for BPA at the current
exposure level.
Message for Consumers
At this time, FDA is not recommending that anyone discontinue
using products that contain BPA while we continue our
risk assessment process. However, concerned consumers
should know that several alternatives to polycarbonate
baby bottles exist, including glass baby bottles.
- FDA Statement on Polycarbonates. 1/29/2008 Statement from
the FDA, from a written communication dated January 29,
2008 The Agency's current position on the presence of BPA
impurities in food-contact polymers is as follows. BPA is
used in the manufacture of two types of polymers used for
food-contact articles (i.e., polycarbonate (PC) polymers
and epoxy-based enamels and coatings) and is present at
very low levels in the finished food contact materials.
Typical uses of PC polymers include food processing equipment,
such as popcorn makers, and water and infant baby bottles
intended for repeated use. BPA-based epoxy coated cans are
used in a variety of canned food and beverage applications,
including cans used to hold infant formula. The Agency is
aware of several reports stating that BPA has estrogen-like
activity. However, there are other reports that appear to
dispute any reason to expect harm at the low exposures that
humans experience. A March 2007 report from a consumer group
included studies showing the levels of BPA found in canned
foods and migrating out of PC baby bottles and included
claims that these levels are unsafe. FDA scientists have
reviewed the available information from this report and
have concluded that the BPA levels found in canned foods
or migrating out of PC baby bottles are not significantly
different than the very low levels previously found by FDA
chemists and other laboratories, levels that result in a
dietary exposure that is orders of magnitude below the levels
known to not cause toxic effects in animals.
The agency has been actively reviewing the safety of BPA
and has completed a review of the available data obtained
from animal studies, and migration studies. Based on the
results of the migration studies conducted by FDA chemists,
we have determined that the dietary exposure to BPA is low
(3.7 ppb), the level that is orders of magnitude below the
levels known to cause toxic effects in animals. Considering
the low dietary exposure and the fact that BPA had not demonstrated
adverse effects when consumed by animals in amounts of much
higher (orders of magnitude) than humans would consume,
FDA sees no reason at this time to ban or otherwise restrict
the uses now authorized. Our conclusion is based on our
ongoing review of all available data. We will continue to
monitor data on BPA to determine if its use would raise
a safety concern. If such a concern exists, FDA will take
the appropriate post-market regulatory action.
|
|
 |
 |
 |
 |
|
